Correlation Between Madrigal Pharmaceuticals and Kiromic Biopharma
Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and Kiromic Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and Kiromic Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Madrigal Pharmaceuticals and Kiromic Biopharma, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and Kiromic Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of Kiromic Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and Kiromic Biopharma.
Diversification Opportunities for Madrigal Pharmaceuticals and Kiromic Biopharma
-0.63 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Madrigal and Kiromic is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and Kiromic Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kiromic Biopharma and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with Kiromic Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kiromic Biopharma has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and Kiromic Biopharma go up and down completely randomly.
Pair Corralation between Madrigal Pharmaceuticals and Kiromic Biopharma
Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to generate 0.35 times more return on investment than Kiromic Biopharma. However, Madrigal Pharmaceuticals is 2.88 times less risky than Kiromic Biopharma. It trades about 0.02 of its potential returns per unit of risk. Kiromic Biopharma is currently generating about -0.01 per unit of risk. If you would invest 30,073 in Madrigal Pharmaceuticals on October 9, 2024 and sell it today you would earn a total of 2,008 from holding Madrigal Pharmaceuticals or generate 6.68% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 26.26% |
| Values | Daily Returns |
Madrigal Pharmaceuticals vs. Kiromic Biopharma
Performance |
| Timeline |
| Madrigal Pharmaceuticals |
| Kiromic Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Madrigal Pharmaceuticals and Kiromic Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Madrigal Pharmaceuticals and Kiromic Biopharma
The main advantage of trading using opposite Madrigal Pharmaceuticals and Kiromic Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, Kiromic Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kiromic Biopharma will offset losses from the drop in Kiromic Biopharma's long position.| Madrigal Pharmaceuticals vs. TG Therapeutics | Madrigal Pharmaceuticals vs. Terns Pharmaceuticals | Madrigal Pharmaceuticals vs. Hepion Pharmaceuticals | Madrigal Pharmaceuticals vs. Viking Therapeutics |
| Kiromic Biopharma vs. Quoin Pharmaceuticals Ltd | Kiromic Biopharma vs. Allarity Therapeutics | Kiromic Biopharma vs. Virax Biolabs Group | Kiromic Biopharma vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |